The case in front of me: tirzepatide · ten days.
I understand the observation; what I do not understand is the mechanism behind it.
I have read the two review articles that come up first and both assert this without a citation to a primary source.
What is actually going on here, physically?
Moving the day by 10 stretches one interval from 7 days to 17 — one interval, and then it is over. At a seven-day half-life the trough at the end of a normal week sits at 50 per cent of the preceding peak. At the end of a 17-day week it sits at 0.5^(17÷7) = 18.6 per cent: a fall of 31.4 percentage points, once, after which every interval is 7 days again. That is the entire pharmacokinetic content of the change. Whether 31.4 points of trough is worth anything is a question about your own tolerability curve rather than about the molecule. A move of 10 days is longer than the interval itself, which makes it not a shift at all but a missed dose followed by a new schedule — and it should be reasoned about as one. Timing changes are made under supervision; nothing here is medical advice.
The short version: for a weekly agent, take it if you are within a few days; if you are close to the next scheduled dose, skip it and resume.
With a one-week half-life dosed weekly, missing one dose means exposure falls by about half over the following week — the same trough you would reach if you simply extended the interval. That is well within the range the agent operates in.
Stated carefully, for a daily agent with a thirteen-hour half-life, a missed dose is a much larger proportional loss. The usual approach is to skip it and take the next scheduled one rather than doubling.
Published missed-dose guidance for the weekly agents in this class specifies a window of about five days, derived directly from the half-life.
Within about five days for a weekly agent, take it. Beyond that, skip and resume.
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemNever double up to catch up. The exposure spike is real and the tolerability cost is immediate.
The published guidance for the weekly agents is broadly: if the missed dose is remembered within about five days, take it and continue on the usual day; if more than five days have passed, skip it and take the next scheduled dose.
Worth being precise here: one missed dose is not a reason to change the schedule or the dose. Two or more is a reason to consider where you are restarting from.
Loss of tolerance during a treatment gap is documented and is the basis for re-titration after an interruption.
Two or more missed weekly doses means considering a lower restarting step.
The honest answer is that a single missed weekly dose is not an event, and that two in a row starts to matter.
If more than two consecutive weekly doses are missed, tolerance to the gastrointestinal effects begins to fade and re-titration from a lower step becomes the sensible approach.
Set a recurring reminder tied to something you already do weekly. The commonest cause of a missed dose is not forgetting the drug but losing track of the day.
The caveat is that anyone on other glucose-lowering medication has an interaction question here that needs a prescriber.
To move your dosing day, move it later and keep three days between doses.
edited 24 Sept 2024 by orla_ferriter — corrected a unit error in the worked example
Changing the regular dosing day is possible and should be done by moving forward, not by squeezing two doses together.
To change your regular dosing day, move the next dose later rather than earlier, keeping at least three days between doses for a weekly agent. Moving earlier compresses the interval and raises exposure.
Half-lives across the class span roughly thirteen hours to one week, which is why the answer is agent-specific.
Set a recurring reminder attached to something you already do weekly.
The relevant arithmetic is that one missed dose of a weekly agent produces a trough about half the usual, which is well inside the normal range.
Never take two doses close together to compensate. The peak exposure is roughly doubled, and gastrointestinal tolerability tracks peak exposure closely.
Peak exposure rather than average exposure drives gastrointestinal tolerability, which is the reason doubling up is advised against.
Never double up. Peak exposure is what drives the symptoms.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.